相关实验视频
Updated: Jul 6, 2025

07:35
Gene Transfer for Ischemic Heart Failure in a Preclinical Model
Published on: May 15, 2011
12.9K
遗传性心律失常和基因疗法:有没有任何需要考虑的伦理考虑?
Michael Spartalis1, Eleftherios Spartalis2, Gerasimos Siasos3
13rd Department of Cardiology, National and Kapodistrian University of Athens, Athens 11527, Greece. msparta@med.uoa.gr.
World journal of cardiology
|January 4, 2024
概括
基因组编辑显示出治疗心脏节律障碍的前景,如心房动和心房动脉动,提供个性化治疗. 然而,对于其在心脏病学中的实施而言,伦理方面的考虑至关重要.
科学领域:
- 心脏病学 心脏病学
- 遗传学 遗传学 是一个
- 医学伦理 医学伦理
背景情况:
- 干预电生理学在过去50年里取得了重大进展.
- 尽管取得了进展,但目前对心律失常的治疗方法仍然不足.
- 诸如心房动和心室低心率等心律失常存在治疗挑战.
研究的目的:
- 探索用于管理心律失常的创新方法.
- 调查基因组编辑作为节律障碍个性化治疗的潜力.
- 考虑在心脏病学中使用基因组编辑的伦理含义.
主要方法:
- 审查干预电生理学的进展.
- 探索基因组编辑技术用于心律失常治疗.
- 分析与个性化遗传疗法相关的伦理问题.
主要成果:
- 基因组编辑对个性化心律失常管理具有重大前景.
- 对于有节律障碍的患者来说,具有高度有效的治疗潜力.
- 确定几个需要仔细考虑的伦理问题.
结论:
- 基因组编辑为治疗复杂心律失常提供了一个有希望的未来.
- 个性化基因组编辑疗法可能会彻底改变心律管理.
- 解决道德问题对于负责任地应用这项技术至关重要.
相关概念视频
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
What is Genetic Engineering?
74.1K
Overview
74.1K
Mechanism of Cardiac Arrhythmias
923
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
923
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.4K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.4K
Heart Failure Drugs: Inotropic Agents
591
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
591
Disturbances in Heart Rhythm
963
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
963

